ASX - By Stock
|
IBX |
Re:
Ann: Imagion to develop nanocrystals for treating breast cancer
|
|
ajdm123
|
92 |
32K |
2 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
92
|
32K
|
2
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
ajdm123
|
529 |
181K |
1 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
529
|
181K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
ajdm123
|
5.5K |
1.9M |
6 |
11/08/21 |
11/08/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
6
|
|
ASX - By Stock
|
IBX |
Re:
To whoever has a crystal ball?
|
|
ajdm123
|
38 |
11K |
2 |
05/08/21 |
05/08/21 |
ASX - By Stock
|
38
|
11K
|
2
|
|
ASX - By Stock
|
IBX |
Re:
To whoever has a crystal ball?
|
|
ajdm123
|
38 |
11K |
5 |
05/08/21 |
05/08/21 |
ASX - By Stock
|
38
|
11K
|
5
|
|
ASX - By Stock
|
IBX |
Re:
To whoever has a crystal ball?
|
|
ajdm123
|
38 |
11K |
5 |
05/08/21 |
05/08/21 |
ASX - By Stock
|
38
|
11K
|
5
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Market Update - PAT-DX1 Clinical Trial Preparation
|
|
ajdm123
|
244 |
75K |
1 |
04/08/21 |
04/08/21 |
ASX - By Stock
|
244
|
75K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Market Update - PAT-DX1 Clinical Trial Preparation
|
|
ajdm123
|
244 |
75K |
0 |
04/08/21 |
04/08/21 |
ASX - By Stock
|
244
|
75K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ajdm123
|
122 |
28K |
3 |
01/08/21 |
01/08/21 |
ASX - By Stock
|
122
|
28K
|
3
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ajdm123
|
122 |
28K |
0 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
122
|
28K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ajdm123
|
122 |
28K |
1 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
122
|
28K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Charting
|
|
ajdm123
|
1.7K |
606K |
4 |
28/07/21 |
28/07/21 |
ASX - By Stock
|
1.7K
|
606K
|
4
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
ajdm123
|
529 |
181K |
7 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
529
|
181K
|
7
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
ajdm123
|
5.5K |
1.9M |
2 |
21/07/21 |
21/07/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
2
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
ajdm123
|
5.5K |
1.9M |
3 |
18/07/21 |
18/07/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
3
|
|
ASX - By Stock
|
IBX |
Re:
Charting
|
|
ajdm123
|
1.7K |
606K |
8 |
16/07/21 |
16/07/21 |
ASX - By Stock
|
1.7K
|
606K
|
8
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
ajdm123
|
529 |
181K |
7 |
10/07/21 |
10/07/21 |
ASX - By Stock
|
529
|
181K
|
7
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
ajdm123
|
529 |
181K |
17 |
07/07/21 |
07/07/21 |
ASX - By Stock
|
529
|
181K
|
17
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
ajdm123
|
529 |
181K |
11 |
07/07/21 |
07/07/21 |
ASX - By Stock
|
529
|
181K
|
11
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
ajdm123
|
529 |
181K |
12 |
07/07/21 |
07/07/21 |
ASX - By Stock
|
529
|
181K
|
12
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
ajdm123
|
529 |
181K |
8 |
07/07/21 |
07/07/21 |
ASX - By Stock
|
529
|
181K
|
8
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
ajdm123
|
529 |
181K |
1 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
529
|
181K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
ajdm123
|
529 |
181K |
6 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
529
|
181K
|
6
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
ajdm123
|
529 |
181K |
7 |
24/06/21 |
24/06/21 |
ASX - By Stock
|
529
|
181K
|
7
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
ajdm123
|
529 |
181K |
19 |
17/06/21 |
17/06/21 |
ASX - By Stock
|
529
|
181K
|
19
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
ajdm123
|
5.5K |
1.9M |
9 |
12/06/21 |
12/06/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
9
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
ajdm123
|
5.5K |
1.9M |
1 |
28/05/21 |
28/05/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
ajdm123
|
5.5K |
1.9M |
4 |
28/05/21 |
28/05/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
4
|
|
ASX - By Stock
|
IBX |
Re:
Ann: AGM presentation
|
|
ajdm123
|
20 |
8.9K |
0 |
28/05/21 |
28/05/21 |
ASX - By Stock
|
20
|
8.9K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
ajdm123
|
5.5K |
1.9M |
0 |
27/05/21 |
27/05/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
ajdm123
|
529 |
181K |
26 |
26/05/21 |
26/05/21 |
ASX - By Stock
|
529
|
181K
|
26
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
ajdm123
|
529 |
181K |
30 |
26/05/21 |
26/05/21 |
ASX - By Stock
|
529
|
181K
|
30
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
ajdm123
|
529 |
181K |
4 |
26/05/21 |
26/05/21 |
ASX - By Stock
|
529
|
181K
|
4
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
ajdm123
|
5.5K |
1.9M |
8 |
26/05/21 |
26/05/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
8
|
|
ASX - By Stock
|
IBX |
Re:
IBX videos
|
|
ajdm123
|
155 |
59K |
11 |
22/05/21 |
22/05/21 |
ASX - By Stock
|
155
|
59K
|
11
|
|
ASX - By Stock
|
IBX |
Re:
Financial incentives for recruiting is not uncommon
|
|
ajdm123
|
13 |
4.6K |
7 |
19/05/21 |
19/05/21 |
ASX - By Stock
|
13
|
4.6K
|
7
|
|
ASX - By Stock
|
IBX |
Re:
IBX videos
|
|
ajdm123
|
155 |
59K |
3 |
18/05/21 |
18/05/21 |
ASX - By Stock
|
155
|
59K
|
3
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
ajdm123
|
5.5K |
1.9M |
8 |
16/05/21 |
16/05/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
8
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
ajdm123
|
5.5K |
1.9M |
5 |
12/05/21 |
12/05/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
5
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
ajdm123
|
5.5K |
1.9M |
6 |
12/05/21 |
12/05/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
6
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
ajdm123
|
5.5K |
1.9M |
8 |
08/05/21 |
08/05/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
8
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
ajdm123
|
5.5K |
1.9M |
11 |
07/05/21 |
07/05/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
11
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
ajdm123
|
5.5K |
1.9M |
14 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
14
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion and Patrys collaborate on new cancer imaging agents
|
|
ajdm123
|
60 |
25K |
8 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
60
|
25K
|
8
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
ajdm123
|
5.5K |
1.9M |
18 |
01/05/21 |
01/05/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
18
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
ajdm123
|
5.5K |
1.9M |
6 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
6
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
ajdm123
|
5.5K |
1.9M |
18 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
18
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Appendix 4C - quarterly
|
|
ajdm123
|
224 |
72K |
9 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
224
|
72K
|
9
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
ajdm123
|
5.5K |
1.9M |
13 |
21/04/21 |
21/04/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
13
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
ajdm123
|
5.5K |
1.9M |
9 |
21/04/21 |
21/04/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
9
|
|